PI-LAB-2025-068

BPC-157, Independent Lab Report

BPC-157 5mg · NextGen Peptides

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 97.5% met the stated ≥98% claim. Content measured 101.2% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
97.5%

Label claimed ≥98%

Content accuracy
101.2%

5.06mg measured against 5mg claimed

Test recency
Older result

Published 20 months ago

Specimen PI-LAB-2025-068 Tested by Meridian Bioanalytical 17 samples tested from this company Purity & Testing score 91/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 97.5% Within analytical tolerance
Identity (MS) BPC-157 Confirmed Matches label
Content 5 mg 5.06 mg Within 5% of label

Methodology & chain of custody

LC-MS/MS identity confirmation with quantitative amino acid analysis.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Meridian Bioanalytical. See our full testing methodology.

Lot / batch
C6096-25
Purchased
Analysed
Published
Laboratory
Meridian Bioanalytical
Test type
Content verification

Original laboratory report: PI-LAB-2025-068-report.pdf (document delivery arrives with the production storage backend)

More Tests, NextGen Peptides

PT-141
Purity 98.5% Verified
Retatrutide
Purity 99.7% Verified
Tirzepatide/Cagrilintide Blend
Purity 97.6% Verified

More Tests, BPC-157

BPC-157 Research Peptides Co.
Purity 98.7% Verified
BPC-157 Quantum Peptide Group
Purity 97.1% Verified
BPC-157 Apex Peptides
Purity 94.9% Verified